Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

Low oxygen areas help maintain and protect blood stem cells by using a simple sugar breakdown process for energy and managing their activity levels.

Stem cells can help other stem cells by producing supportive factors.

Certain chemotherapy drugs can cause permanent hair loss in stem cell transplant patients.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Robotic hair transplantation with AI offers more reliable, precise, and efficient hair restoration.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Patients with Shwachman-Diamond syndrome often get misdiagnosed due to a wide range of symptoms, including immune system problems and bone abnormalities.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Changing the environment around stem cells could help tissue repair, but it's hard to be precise and avoid side effects.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Certain signals and genes play a key role in hair growth and regeneration, and understanding these could lead to new treatments for skin regeneration.

Skin issues can indicate immune system problems.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Protoporphyrin IX is useful in cancer treatment but can cause health problems if not properly regulated.